Skip to main content

Table 4 Odds ratios and 95% confidence intervals (CI) for genotype as predictor of sustained virological response after treatment with peginterferon and ribavirin in 432 chronically HCV infected patients, divided by age

From: Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study

   Age ≤ 45 years Age > 45 years
   Odds ratio (95% CI)* Odds ratio (95% CI)*
Genotype 1 1 1
  2/3 1.42 (0.62-3.24) 3.00 (1.65-5.47)
  1. *adjusted for gender, nationality, route of infection, HCV-RNA, ALT, treating department (gastroenterology/hepatology vs. infectious diseases), treatment completion as scheduled, ended before scheduled or dose reduction